Research status and progress of the RNA or protein biomarkers for prostate cancer
- PMID: 30962694
- PMCID: PMC6434918
- DOI: 10.2147/OTT.S194138
Research status and progress of the RNA or protein biomarkers for prostate cancer
Abstract
Prostate cancer is a kind of male malignancy. Recently, a large number of studies have reported many potential biomarkers for the diagnosis and prognosis of prostate cancer. In this literature review, we have collected a number of potential biomarkers for prostate cancer reported in the last 5 years. Among them, some are undergoing Phase III clinical trials, and others have been approved by the US Food and Drug Administration. However, most are still in the period of basic research. The review will contribute to future research to find the biomarkers to guide clinicians to make personalized treatment decisions for each prostate cancer patient.
Keywords: TMPRSS2-ERG; fusion gene; lncRNAs; methylation; microRNAs.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
-
- Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. - PubMed
-
- Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society Prostate Cancer Advisory Committee American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin. 2010;60(2):70–98. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
